Intellia Therapeutics(NTLA) - 2020 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 36-4785571 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identification No.) 40 Erie Street, Suite 130, Cambridge, Massachusetts 02139 (Address of Principal Executive Offices) (Zip Code) 857-285-6200 (Registrant's Telephone Number, Including Area Code) For the quarterly period ended March 31, 202 ...